United States · FDA National Drug Code directory
Tobramycin
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 76204-029_459f9e6a-cdbc-32cb-e063-6294a90a03e3
- Product NDC
- 76204-029
- Form
- SOLUTION
- Composition / generic term
- Tobramycin
- Labeler
- Ritedose Pharmaceuticals, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20250325
- Source listing expiry
- 20261231
Source-listed ingredients
- TOBRAMYCIN — 300 mg/5mL
These values do not establish equivalence or a dose recommendation.
Packages
- 14 POUCH in 1 CARTON (76204-029-56) / 4 AMPULE in 1 POUCH / 5 mL in 1 AMPULE · 76204-029-56
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →